Size | Price | Stock | Qty |
---|---|---|---|
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
2g |
|
||
Other Sizes |
|
Purity: ≥98%
Trans-Zeatin is a cytokinin/plant hormone that is crucial for cell growth, differentiation, and division.It also encourages the development of lateral buds, seeds, and seedlings, as well as cell division. A plant cytokinin is called trans-Zeatin. Additionally, Trans-Zeatin prevents UV-induced MEK/ERK activation.
Targets |
MMP-1; ERK; JNK; p38 MAPK
|
---|---|
ln Vitro |
Trans-Zeatin pretreatment significantly reduces the amount of UVB-induced MMP-1 expression and c-Jun activation in cultured human skin fibroblasts. This effect may be due to the inhibition of the ERK, JNK, and p38 MAPK signaling pathways[1].
|
Cell Assay |
In a 96-well plate, HSFs are sown. Cells are cultured in 100 μl of 10% DMEM in each well for the specified amount of time after receiving varying doses of trans-Zeatin or UVB treatment. The cells are then incubated for 4 hours at 37 °C with 10 μl of MTT solution at a concentration of 5 mg/ml in each well. After removing the medium, each well receives 200 μl of DMSO, which is then pipetted up and down repeatedly to dissolve the formazan crystals. A spectrophotometer is used to measure the absorbance at a wavelength of 570 nm on an ELISA plate reader.
|
Toxicity/Toxicokinetics |
Interactions
... Zeatin mitigated cognitive deficits and showed AChE inhibition in scopolamine (Scop)-induced mice following 21 days of zeatin treatment. After administration of Scop for 30 min, each mouse performed Y-maze and step-down latency tasks as a check on immediate against cognitive function. The results showed that zeatin administration attenuated Scop-induced memory damage and decreased AChE activity in the mice... Non-Human Toxicity Values LD50 Rat oral >5 g/kg /from table/ /Cytokinin/ LD50 Rabbit dermal >2 g/kg /from table/ /Cytokinin/ |
References | |
Additional Infomation |
Zeatin is a 6-isopentenylaminopurine. It has a role as a cytokinin.
An aminopurine factor in plant extracts that induces cell division. (Grant & Hackh's Chemical Dict, 5th ed) trans-Zeatin has been reported in Mercurialis ambigua, Solanum tuberosum, and other organisms with data available. An aminopurine factor in plant extracts that induces cell division. (Grant and Hackh's Chemical Dict, 5th ed) Mechanism of Action Kinetin stimulated phosphorylation of protein in floated Chinese-cabbage leaf discs, but inhibited protein phosphorylation in nuclei+chloroplast extracts from Chinese-cabbage or tobacco leaves. Kinetin also inhibited protein phosphorylation in isolated tobacco nuclei or nuclei from carrot secondary-phloem tissue. Purified Chinese-cabbage leaf ribosomes exhibited protein kinase activity which was inhibited by kinetin and zeatin. The ribosome-associated kinase responded to kinetin and zeatin differently from that associated with nuclei+chloroplast preparations. Protein phosphorylation in vitro was not affected by adenosine 3':5'-cyclic monophosphate, indol-3-ylacetic acid or gibberellic acid. It was only inhibited by N(9)-unsubstituted purines, among which the known cytokinins were the most effective inhibitors. The results are discussed in relation to possible similarities between the effects of cytokinins in plant tissues and the effects of adenosine 3':5'-cyclic monophosphate in animal tissues. Both compounds appear to modify the activity of protein kinases and both affect many different cellular processes. Therapeutic Uses /EXPL THER/ In this study, our aim was to clarify the ameliorative effects of zeatin, a development hormone in plants. Zeatin mitigated cognitive deficits and showed AChE inhibition in scopolamine (Scop)-induced mice following 21 days of zeatin treatment. After administration of Scop for 30 min, each mouse performed Y-maze and step-down latency tasks as a check on immediate against cognitive function. The results showed that zeatin administration attenuated Scop-induced memory damage and decreased AChE activity in the mice. This suggests that zeatin might be useful for protecting cognitive dysfunction, as well as for reducing the activation of AChE in dementia. |
Molecular Formula |
C10H13N5O
|
---|---|
Molecular Weight |
219.2431
|
Exact Mass |
219.112
|
Elemental Analysis |
C, 54.78; H, 5.98; N, 31.94; O, 7.30
|
CAS # |
1637-39-4
|
Related CAS # |
trans-Zeatin-d5;72963-19-0
|
PubChem CID |
449093
|
Appearance |
White to off-white solid powder
|
Density |
1.4±0.1 g/cm3
|
Boiling Point |
395.0±52.0 °C at 760 mmHg
|
Melting Point |
207 °C
|
Flash Point |
192.7±30.7 °C
|
Vapour Pressure |
0.0±2.1 mmHg at 25°C
|
Index of Refraction |
1.684
|
LogP |
-1.02
|
Hydrogen Bond Donor Count |
3
|
Hydrogen Bond Acceptor Count |
5
|
Rotatable Bond Count |
4
|
Heavy Atom Count |
16
|
Complexity |
258
|
Defined Atom Stereocenter Count |
0
|
SMILES |
O([H])C([H])([H])/C(/C([H])([H])[H])=C(\[H])/C([H])([H])N([H])C1C2=C(N=C([H])N=1)N=C([H])N2[H]
|
InChi Key |
UZKQTCBAMSWPJD-FARCUNLSSA-N
|
InChi Code |
InChI=1S/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2+
|
Chemical Name |
(E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol
|
Synonyms |
Trans Zeatin; (E)-Zeatin; Zeatine; Zeatin
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: 25~43 mg/mL (114.0~196.1 mM)
Ethanol: ~2 mg/mL (~9.1 mM) |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (5.70 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (5.70 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 1.25 mg/mL (5.70 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.5612 mL | 22.8061 mL | 45.6121 mL | |
5 mM | 0.9122 mL | 4.5612 mL | 9.1224 mL | |
10 mM | 0.4561 mL | 2.2806 mL | 4.5612 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.